Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
Clinical trial NCT03515044 · COMPLETED
Trial details
- NCT number
- NCT03515044
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2020-03-12
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.